Suppr超能文献

术前血清CA-125在子宫浆液性乳头状癌管理中的应用

Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.

作者信息

Olawaiye Alexander B, Rauh-Hain Jose Alejandro, Withiam-Leitch Matthew, Rueda Bo, Goodman Annekathryn, del Carmen Marcela G

机构信息

Department of Obstetrics, Division of Gynecologic Oncology, Harvard Medical School, Vincent Obstetrics and Gynecology Service, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

出版信息

Gynecol Oncol. 2008 Sep;110(3):293-8. doi: 10.1016/j.ygyno.2008.05.027. Epub 2008 Jul 21.

Abstract

OBJECTIVE

To evaluate the usefulness of pre-operative serum CA-125 in the management of women diagnosed with uterine papillary serous carcinoma (UPSC). We hypothesized that elevated pre-operative levels of serum CA-125 correlate with higher disease stage and poorer prognosis.

METHODS

Patients diagnosed with UPSC and managed in our institution were identified over a period of 10 years, 1995 to 2005. All required information were extracted from their records. The nonparametric test applied for comparison of data included Kruskal Wallis H-test and Man-Whitney U-test. The chi(2) test and Spearman correlation test were used to examine the association of serum CA-125 with different parameters. Receiver operator characteristic curves (ROC) were used to quantify marker performance. Recurrence and survival were analyzed using Kaplan-Meier method. Multivariate analyses were performed with a Cox proportional regression method.

RESULTS

A total of 41 patients met the study criteria. Mean pre-operative serum CA-125 levels were significantly higher in patients with stage IV (1150+/-1297 U/mL), compared with stage III (181+/-232 U/mL; P<0.001), stage II (22+/-9; P<0.001), and stage I (14+/-1; P<0.001). CA-125 correlated strongly with stage (r=0.68, P<0.001). On the ROC, a cut-off of 35 IU/mL provided the best sensitivity and specificity (78% vs. 100% respectively) for extra-uterine disease. Disease free survival (DFS) and overall survival (OS) were longer in patients with CA-125<35 U/mL compared with CA-125>or=35 U/mL [median DFS not reached during study vs. 21.2 months (P=0.009), and median OS not reached during study vs. 25 months, (P=0.0001) respectively]. Multivariate regression model showed CA-125 as the only variable associated with survival (P=0.05).

CONCLUSION

Pre-operative serum CA-125 levels correlate with stage of disease in patients with UPSC. This may be important for management planning, prognostication and counseling in these women.

摘要

目的

评估术前血清CA - 125在子宫浆液性乳头状癌(UPSC)患者管理中的作用。我们假设术前血清CA - 125水平升高与疾病分期较高及预后较差相关。

方法

确定1995年至2005年期间在我们机构诊断并接受治疗的UPSC患者。从他们的记录中提取所有所需信息。用于数据比较的非参数检验包括Kruskal Wallis H检验和Mann - Whitney U检验。使用卡方检验和Spearman相关检验来检查血清CA - 125与不同参数之间的关联。采用受试者操作特征曲线(ROC)来量化标志物性能。使用Kaplan - Meier方法分析复发和生存情况。采用Cox比例回归方法进行多变量分析。

结果

共有41例患者符合研究标准。IV期患者术前血清CA - 125平均水平(1150±1297 U/mL)显著高于III期(181±232 U/mL;P<0.001)、II期(22±9;P<0.001)和I期(14±1;P<0.001)患者。CA - 125与分期密切相关(r = 0.68,P<0.001)。在ROC曲线上,35 IU/mL的临界值对子宫外疾病具有最佳的敏感性和特异性(分别为78%和100%)。与CA - 125≥35 U/mL的患者相比,CA - 125<35 U/mL的患者无病生存期(DFS)和总生存期(OS)更长[研究期间未达到中位DFS,而中位DFS为21.2个月(P = 0.009),研究期间未达到中位OS,而中位OS为25个月,(P = 0.0001)]。多变量回归模型显示CA - 125是与生存相关的唯一变量(P = 0.05)。

结论

术前血清CA - 125水平与UPSC患者的疾病分期相关。这对于这些女性的管理规划、预后评估和咨询可能很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验